Neurosyphilis primary prevention: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Tabes dorsalis}}
{{Neurosyphilis}}
{{CMG}}{{AE}}{{MMJ}}{{AA}}
{{CMG}}{{AE}}{{MMJ}}{{AA}}
==Overview==
==Overview==
Line 23: Line 23:


[[Category:Gynecology]]
[[Category:Gynecology]]
 
[[Category:Emergency mdicine]]
[[Category:Primary care]]
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Primary care]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Gynecology]]
[[Category:Urology]]
[[Category:Urology]]
[[Category:Neurology]]
[[Category:Neurology]]

Latest revision as of 22:58, 29 July 2020

Neurosyphilis Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Neurosyphilis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurosyphilis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurosyphilis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurosyphilis primary prevention

CDC on Neurosyphilis primary prevention

Neurosyphilis primary prevention in the news

Blogs on Neurosyphilis primary prevention

Directions to Hospitals Treating Neurosyphilis

Risk calculators and risk factors for Neurosyphilis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]Aysha Anwar, M.B.B.S[3]

Overview

There is no vaccine available for prevention of syphilis. However, effective measures for the primary prevention of syphilis include abstinence from intimate physical contact with an infected person, consistent use of latex condoms, limiting number of sexual partners, avoidance of sharing sex toys, practising safe sex, routine screening in pregnant females, individuals with high risk behaviours, and those residing in highly prevalent areas. In patients with diagnosed syphilis, early treatment with penicillin can widely prevent neurosyphilis.

Primary prevention

There is no vaccine available for prevention of syphilis. Effective measures for the primary prevention of syphilis include:[1][2][3]

  • Abstinence from intimate physical contact with an infected person
  • Consistent use of latex condoms
  • Limiting number of sexual partners
  • Avoid sharing sex toys
  • Practicing safe sex
  • Routine screening in pregnant females, individuals with high risk behaviors, and those residing in highly prevalent areas
Primary Prevention of Neurosyphilis
  • In patients with diagnosed syphilis, early treatment with penicillin can widely prevent neurosyphilis.[4]

References

  1. Stamm LV (2010). "Global challenge of atibiotic-resistant Treponema pallidum". Antimicrobial Agents and Chemotherapy. 54 (2): 583–9. doi:10.1128/AAC.01095-09. PMC 2812177. PMID 19805553. Retrieved 2012-02-21. Unknown parameter |month= ignored (help)
  2. Cameron CE, Lukehart SA (2014). "Current status of syphilis vaccine development: need, challenges, prospects". Vaccine. 32 (14): 1602–9. doi:10.1016/j.vaccine.2013.09.053. PMC 3951677. PMID 24135571.
  3. http://www.cdc.gov/std/tg2015/syphilis.htm Accessed on September 27, 2016
  4. Musher DM (1991). "Syphilis, neurosyphilis, penicillin, and AIDS". J Infect Dis. 163 (6): 1201–6. PMID 2037785.


Template:WikiDoc Sources